160 related articles for article (PubMed ID: 25253020)
1. Btbd7 contributes to reduced E-cadherin expression and predicts poor prognosis in non-small cell lung cancer.
Fan C; Miao Y; Zhang X; Liu D; Jiang G; Lin X; Han Q; Luan L; Xu Z; Wang E
BMC Cancer; 2014 Sep; 14():704. PubMed ID: 25253020
[TBL] [Abstract][Full Text] [Related]
2. BTBD7 Downregulates E-Cadherin and Promotes Epithelial-Mesenchymal Transition in Lung Cancer.
Shu J; Wang L; Han F; Chen Y; Wang S; Luo F
Biomed Res Int; 2019; 2019():5937635. PubMed ID: 31886230
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of CASS4 promotes invasion in non-small cell lung cancer by activating the AKT signaling pathway and inhibiting E-cadherin expression.
Li A; Zhang W; Xia H; Miao Y; Zhou H; Zhang X; Dong Q; Li Q; Qiu X; Wang E
Tumour Biol; 2016 Nov; 37(11):15157-15164. PubMed ID: 27677288
[TBL] [Abstract][Full Text] [Related]
4. RETRACTED: Btbd7 is essential for region-specific epithelial cell dynamics and branching morphogenesis
Daley WP; Matsumoto K; Doyle AD; Wang S; DuChez BJ; Holmbeck K; Yamada KM
Development; 2017 Jun; 144(12):2200-2211. PubMed ID: 28506999
[TBL] [Abstract][Full Text] [Related]
5. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
6. delta-Catenin promotes malignant phenotype of non-small cell lung cancer by non-competitive binding to E-cadherin with p120ctn in cytoplasm.
Zhang JY; Wang Y; Zhang D; Yang ZQ; Dong XJ; Jiang GY; Zhang PX; Dai SD; Dong QZ; Han Y; Zhang S; Cui QZ; Wang EH
J Pathol; 2010 Sep; 222(1):76-88. PubMed ID: 20593408
[TBL] [Abstract][Full Text] [Related]
7. Expression of BTBD7 in primary salivary adenoid cystic carcinoma and correlation with Slug and prognosis.
Yang L; Wang T; Zhang J; Liu Z; Wang X
Cancer Biomark; 2016 Jun; 17(2):179-85. PubMed ID: 27540976
[TBL] [Abstract][Full Text] [Related]
8. Coiled-coil domain-containing protein 8 inhibits the invasiveness and migration of non-small cell lung cancer cells.
Jiang GY; Zhang XP; Zhang Y; Xu HT; Wang L; Li QC; Wang EH
Hum Pathol; 2016 Oct; 56():64-73. PubMed ID: 27342910
[TBL] [Abstract][Full Text] [Related]
9. BTBD7 silencing inhibited epithelial- mesenchymal transition (EMT) via regulating Slug expression in human salivary adenoid cystic carcinoma.
Yang L; Wang T; Zhang J; Wang X
Cancer Biomark; 2017 Dec; 20(4):461-468. PubMed ID: 28946551
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer.
Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Yang LH; Liu Y; Wang EH
Pathol Oncol Res; 2013 Apr; 19(2):281-6. PubMed ID: 23086683
[TBL] [Abstract][Full Text] [Related]
11. Expression of p130cas, E-cadherin and β-catenin and their correlation with clinicopathological parameters in non-small cell lung cancer: p130cas over-expression predicts poor prognosis.
Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Han Y; Liu Y; Wang E
Folia Histochem Cytobiol; 2012 Oct; 50(3):392-7. PubMed ID: 23042269
[TBL] [Abstract][Full Text] [Related]
12. Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer.
Sulzer MA; Leers MP; van Noord JA; Bollen EC; Theunissen PH
Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1319-23. PubMed ID: 9563756
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
14. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
[TBL] [Abstract][Full Text] [Related]
15. [Expressions of E-cadherin in non-small cell lung cancer and it correlation with prognosis].
Qiao GB; Wu YL; Ou W; Yang XN; Zhong WZ; Lin JY; Zhao J; Xie D; Guan XY
Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(14):913-7. PubMed ID: 16083620
[TBL] [Abstract][Full Text] [Related]
16. Beclin 1 and p62 expression in non-small cell lung cancer: relation with malignant behaviors and clinical outcome.
Wang X; Du Z; Li L; Shi M; Yu Y
Int J Clin Exp Pathol; 2015; 8(9):10644-52. PubMed ID: 26617774
[TBL] [Abstract][Full Text] [Related]
17. Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance.
Kase S; Sugio K; Yamazaki K; Okamoto T; Yano T; Sugimachi K
Clin Cancer Res; 2000 Dec; 6(12):4789-96. PubMed ID: 11156236
[TBL] [Abstract][Full Text] [Related]
18. The Role of BTBD7 in Normal Development and Tumor Progression.
Liu Y; Song J; Gu J; Xu S; Wang X; Liu Y
Technol Cancer Res Treat; 2023; 22():15330338231167732. PubMed ID: 37050886
[TBL] [Abstract][Full Text] [Related]
19. High expression of P-cadherin is significantly associated with poor prognosis in patients with non-small-cell lung cancer.
Imai S; Kobayashi M; Takasaki C; Ishibashi H; Okubo K
Lung Cancer; 2018 Apr; 118():13-19. PubMed ID: 29571991
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer.
Kimura K; Endo Y; Yonemura Y; Heizmann CW; Schafer BW; Watanabe Y; Sasaki T
Int J Oncol; 2000 Jun; 16(6):1125-31. PubMed ID: 10811984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
